Fujian Cosunter Pharmaceutical Co. Ltd
5 clinical trials · Sponsor
◉ Watch Fujian Cosunter Pharmaceutical Co. Ltd
| Record | Firm | Date |
|---|---|---|
| Phase I Study of GST-HG151 Tablets in Healthy Volunteers (NCT05345964) | Fujian Cosunter Pharmaceutical Co. Ltd | 2022-03-07 |
| Study on the Tolerability, Pharmacodynamics and Pharmacokinetics of GST-HG141 Tablets (NCT04868981) | Fujian Cosunter Pharmaceutical Co. Ltd | 2021-05-31 |
| Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of GST-HG131 Tablets (NCT04499443) | Fujian Cosunter Pharmaceutical Co. Ltd | 2020-08-18 |
| Study on the Tolerance and Pharmacokinetics of GST-HG141 Tablets (NCT04386915) | Fujian Cosunter Pharmaceutical Co. Ltd | 2020-05-18 |
| Safety, Tolerability, Pharmacokinetic Characteristics, and Preliminary Efficacy Evaluation of GST-HG161 (NCT04228406) | Fujian Cosunter Pharmaceutical Co. Ltd | 2019-07-01 |
Track Fujian Cosunter Pharmaceutical Co. Ltd automatically
Every clearance here is in the API, with alerts when new ones post.